Reference number : GC-2013-Q1-22929, amendment number : , agreement type : C, recipient legal name : KALGENE PHARMACEUTICALS INC., recipient country : CA, recipient province : nan, recipient city : Vancouver, British Columbia|Vancouver, Colombie-Britannique, recipient postal code : nan, program name english : nan, program name french : nan, program purpose english : To support a firm in the Pharmaceutical and medicine manufacturing (NAICS: 325410)  with a research and development project, program purpose french : Pour supporter une compagnie dans le secteur Fabrication de produits pharmaceutiques et de médicaments (SCIAN: 325410)  dans un projet de recherche et développment, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 174000.0, agreement start date : 2012-03-23, agreement end date : nan, description english : nan, description french : nan, expected results english : nan, expected results french : nan, additional information english : Award spanning more than one fiscal year. Original reporting period: 2012-2013 - 1st quarter, additional information french : Octroi s'appliquant à plus d'un exercice. Trimestre de divulgation originale: 2012-2013 - 1er trimestre, owner organization : nrc-cnrc, owner organization title : National Research Council Canada | Conseil national de recherches Canada